FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Robert Stern

Research Profile

Disorders

Procedures

Concepts & Ideas

Geographic Areas

United States

Occupations

Dermatology

Chemicals & Drugs

Activities & Behaviors

Questionnaires

Co-author Network

Publications

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Robert Stern (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Robert S Stern
Cost effectiveness of Mohs micrographic surgery.
The Journal of investigative dermatology 2013;133(5):1129-31.
2012: Robert S Stern
Clinical practice. Exanthematous drug eruptions.
The New England journal of medicine 2012;366(26):2492-501.
2012: Peggy A Wu; Robert S Stern
Topical tretinoin, another failure in the pursuit of practical chemoprevention for non-melanoma skin cancer.
The Journal of investigative dermatology 2012;132(6):1532-5.
2012: Robert S Stern
The risk of squamous cell and basal cell cancer associated with psoralen and ultraviolet A therapy: a 30-year prospective study.
Journal of the American Academy of Dermatology 2012;66(4):553-62.
2012: Tamar Nijsten; Robert S Stern
How epidemiology has contributed to a better understanding of skin disease.
The Journal of investigative dermatology 2012;132(3 Pt 2):994-1002.
2010: Robert S Stern
Poor metrics and lost opportunity.
Journal of the American Academy of Dermatology 2010;63(4):718-9.
2010: Robert S Stern
Psoriasis is not a useful independent risk factor for cardiovascular disease.
The Journal of investigative dermatology 2010;130(4):917-9.
2010: Robert S Stern
Prevalence of a history of skin cancer in 2007: results of an incidence-based model.
Archives of dermatology 2010;146(3):279-82.
2008: Tamar Nijsten; Phyllis Spuls; Robert S Stern
STROBE: a Beacon for observational studies.
Archives of dermatology 2008;144(9):1200-4.
2007: Robert S Stern
Chronic medication use and inflammatory skin diseases: the power and limitations of the case-control study.
The Journal of investigative dermatology 2007;127(12):2709-10.
2007: Tamar Nijsten; Caspar W N Looman; Robert S Stern
Clinical severity of psoriasis in last 20 years of PUVA study.
Archives of dermatology 2007;143(9):1113-21.
2007: Dimitrios Malanos; Robert S Stern
Psoralen plus ultraviolet A does not increase the risk of cataracts: a 25-year prospective study.
Journal of the American Academy of Dermatology 2007;57(2):231-7.
2007: María Jones-Caballero; Jane Unaeze; Pablo F Peñas; Robert S Stern
Use of biological agents in patients with moderate to severe psoriasis: a cohort-based perspective.
Archives of dermatology 2007;143(7):846-50.
2007: Tamar Nijsten; Francesca Sampogna; Robert S Stern; Damiano Abeni
The reduced Impact of Psoriasis Questionnaire has good psychometric properties in Italian patients.
Dermatology (Basel, Switzerland) 2007;215(4):348-51.
2006: Robert S Stern
Lymphoma risk in psoriasis: results of the PUVA follow-up study.
Archives of dermatology 2006;142(9):1132-5.
2006: Jane Unaeze; Tamar Nijsten; Amy Murphy; Caitlin Ravichandran; Robert S Stern
Impact of psoriasis on health-related quality of life decreases over time: an 11-year prospective study.
The Journal of investigative dermatology 2006;126(7):1480-9.
2006: Tamar Nijsten; Jane Unaeze; Robert S Stern
Refinement and reduction of the Impact of Psoriasis Questionnaire: classical test theory vs. Rasch analysis.
The British journal of dermatology 2006;154(4):692-700.
2005: Joel M Gelfand; Dafna D Gladman; Philip J Mease; Nana Smith; David J Margolis; Tamar Nijsten; Robert S Stern; Steven R Feldman; Tara Rolstad
Epidemiology of psoriatic arthritis in the population of the United States.
Journal of the American Academy of Dermatology 2005;53(4):573.
2005: Tamar Nijsten; Diane Whalley; Joel M Gelfand; David Margolis; Stephen P McKenna; Robert S Stern
The psychometric properties of the psoriasis disability index in United States patients.
The Journal of investigative dermatology 2005;125(4):665-72.
2005: Robert S Stern
Utilization of hospital and outpatient care for adverse cutaneous reactions to medications.
Pharmacoepidemiology and drug safety 2005;14(10):677-84.
2005: Tamar Nijsten; David J Margolis; Steven R Feldman; Tara Rolstad; Robert S Stern
Traditional systemic treatments have not fully met the needs of psoriasis patients: results from a national survey.
Journal of the American Academy of Dermatology 2005;52(3 Pt 1):434-44.
2005: Jean Lee Lim; Robert S Stern
High levels of ultraviolet B exposure increase the risk of non-melanoma skin cancer in psoralen and ultraviolet A-treated patients.
The Journal of investigative dermatology 2005;124(3):505-13.
2005: Tamar Nijsten; Tara Rolstad; Steven R Feldman; Robert S Stern
Members of the national psoriasis foundation: more extensive disease and better informed about treatment options.
Archives of dermatology 2005;141(1):19-26.
2005: Joel M Gelfand; Robert S Stern; Tamar Nijsten; Steven R Feldman; John Thomas; Joe Kist; Tara Rolstad; David J Margolis
The prevalence of psoriasis in African Americans: results from a population-based study.
Journal of the American Academy of Dermatology 2005;52(1):23-6.
2004: Joel M Gelfand; Steven R Feldman; Robert S Stern; John Thomas; Tara Rolstad; David J Margolis
Determinants of quality of life in patients with psoriasis: a study from the US population.
Journal of the American Academy of Dermatology 2004;51(5):704-8.
2004: Robert S Stern
Clinical practice. Treatment of photoaging.
The New England journal of medicine 2004;350(15):1526-34.
2004: Robert S Stern; Tamar Nijsten; Tamar Njisten
Insuring rapid and robust safety assessment.
The Journal of investigative dermatology 2004;122(3):857-8.
2004: Robert S Stern; Tamar Nijsten; Steven R Feldman; David J Margolis; Tara Rolstad
Psoriasis is common, carries a substantial burden even when not extensive, and is associated with widespread treatment dissatisfaction.
The journal of investigative dermatology. Symposium proceedings / the Society for Investigative Dermatology, Inc. [and] European Society for Dermatological Research 2004;9(2):136-9.
2004: Robert S Stern
Dermatologists and office-based care of dermatologic disease in the 21st century.
The journal of investigative dermatology. Symposium proceedings / the Society for Investigative Dermatology, Inc. [and] European Society for Dermatological Research 2004;9(2):126-30.
2003: Tamar Nijsten; Robert S Stern
Oral retinoid use reduces cutaneous squamous cell carcinoma risk in patients with psoriasis treated with psoralen-UVA: a nested cohort study.
Journal of the American Academy of Dermatology 2003;49(4):644-50.
2003: Robert S Stern
Inpatient hospital care for psoriasis: a vanishing practice in the United States.
Journal of the American Academy of Dermatology 2003;49(3):445-50.
2003: Tamar Nijsten; Robert S Stern
The increased risk of skin cancer is persistent after discontinuation of psoralen+ultraviolet A: a cohort study.
The Journal of investigative dermatology 2003;121(2):252-8.
2003: Robert S Stern
Actinic degeneration and pigmentary change in association with psoralen and UVA treatment: a 20-year prospective study.
Journal of the American Academy of Dermatology 2003;48(1):61-7.
2002: Robert S Stern; Svetlana V Bolshakov; Arun J Nataraj; Honnavara N Ananthaswamy
p53 mutation in nonmelanoma skin cancers occurring in psoralen ultraviolet a-treated patients: evidence for heterogeneity and field cancerization.
The Journal of investigative dermatology 2002;119(2):522-6.
2002: Tamar Nijsten; Robert S Stern
Genital squamous cell carcinoma in men treated by photochemotherapy. A cancer registry-based study from 1978 to 1998.
The British journal of dermatology 2002;147(1):184-5; author reply 185-6.
2002: Robert S Stern; Sepideh Bagheri; Khanh Nichols
The persistent risk of genital tumors among men treated with psoralen plus ultraviolet A (PUVA) for psoriasis.
Journal of the American Academy of Dermatology 2002;47(1):33-9.
2002: Kenneth A Katz; Isabelle Marcil; Robert S Stern
Incidence and risk factors associated with a second squamous cell carcinoma or basal cell carcinoma in psoralen + ultraviolet a light-treated psoriasis patients.
The Journal of investigative dermatology 2002;118(6):1038-43.
2002: Robert S Stern
Medicare reimbursement policy and teaching physicians' behavior in hospital clinics: the changes of 1996.
Academic medicine : journal of the Association of American Medical Colleges 2002;77(1):65-71.
2001: Isabelle Marcil; Robert S Stern
Squamous-cell cancer of the skin in patients given PUVA and ciclosporin: nested cohort crossover study.
Lancet 2001;358(9287):1042-5.
2001: Robert S Stern
The risk of melanoma in association with long-term exposure to PUVA.
Journal of the American Academy of Dermatology 2001;44(5):755-61.
2001: Gerald Krueger; J Koo; Mark Lebwohl; Alan Menter; Robert S Stern; Tara Rolstad
The impact of psoriasis on quality of life: results of a 1998 National Psoriasis Foundation patient-membership survey.
Archives of dermatology 2001;137(3):280-4.
2000: Isabelle Marcil; Robert S Stern
Risk of developing a subsequent nonmelanoma skin cancer in patients with a history of nonmelanoma skin cancer: a critical review of the literature and meta-analysis.
Archives of dermatology 2000;136(12):1524-30.
2000: Robert S Stern
Medication and medical service utilization for acne 1995-1998.
Journal of the American Academy of Dermatology 2000;43(6):1042-8.
2000: Robert S Stern; KA Arndt
Top-cited dermatology authors publishing in 5 "high-impact" general medical journals.
Archives of dermatology 2000;136(3):357-61.
1999: Robert S Stern; Janusz Z Beer; D K Mills
Lack of consensus among experts on the choice of UV therapy for psoriasis.
Archives of dermatology 1999;135(10):1187-92.
1999: Robert S Stern; KA Arndt
Growth of international contributors to dermatologic literature.
Archives of dermatology 1999;135(9):1074-6.
1999: Robert S Stern; KA Arndt
Classic and near-classic articles in the dermatologic literature.
Archives of dermatology 1999;135(8):948-50.
1999: Robert S Stern; KA Arndt
Top cited authors in dermatology: a citation study from 24 journals: 1982-1996.
Archives of dermatology 1999;135(3):299-302.
1999: Robert S Stern
Malignant melanoma in patients treated for psoriasis with PUVA.
Photodermatology, photoimmunology & photomedicine 1999;15(1):37-8.
1998: Robert S Stern
Photocarcinogenicity of drugs.
Toxicology letters 1998;102-103():389-92.
1998: Robert S Stern; E J Lunder
Risk of squamous cell carcinoma and methoxsalen (psoralen) and UV-A radiation (PUVA). A meta-analysis.
Archives of dermatology 1998;134(12):1582-5.
1998: E J Lunder; Robert S Stern
Merkel-cell carcinomas in patients treated with methoxsalen and ultraviolet A radiation.
The New England journal of medicine 1998;339(17):1247-8.
1998: Robert S Stern; E J Liebman; LH Väkevä
Oral psoralen and ultraviolet-A light (PUVA) treatment of psoriasis and persistent risk of nonmelanoma skin cancer. PUVA Follow-up Study.
Journal of the National Cancer Institute 1998;90(17):1278-84.
1998: Robert S Stern
Managed care and the treatment of skin disease, 1995. Continued growth and emerging dominance.
Archives of dermatology 1998;134(9):1089-91.
1998: Robert S Stern; D K Mills; K Krell; Barbara Z Zmudzka; Janusz Z Beer
HIV-positive patients differ from HIV-negative patients in indications for and type of UV therapy used.
Journal of the American Academy of Dermatology 1998;39(1):48-55.
1997: Robert S Stern
Psoriasis.
Lancet 1997;350(9074):349-53.
1997: Robert S Stern; LH Väkevä
Noncutaneous malignant tumors in the PUVA follow-up study: 1975-1996.
The Journal of investigative dermatology 1997;108(6):897-900.
1997: Robert S Stern; K T Nichols; LH Väkevä
Malignant melanoma in patients treated for psoriasis with methoxsalen (psoralen) and ultraviolet A radiation (PUVA). The PUVA Follow-Up Study.
The New England journal of medicine 1997;336(15):1041-5.
1997: K E McKenna; Robert S Stern
The impact of psoriasis on the quality of life of patients from the 16-center PUVA follow-up cohort.
Journal of the American Academy of Dermatology 1997;36(3 Pt 1):388-94.
1997: S Goyal; K A Arndt; Robert S Stern; D O'Hare; J S Dover
Laser treatment of tattoos: a prospective, paired, comparison study of the Q-switched Nd:YAG (1064 nm), frequency-doubled Q-switched Nd:YAG (532 nm), and Q-switched ruby lasers.
Journal of the American Academy of Dermatology 1997;36(1):122-5.
1996: Robert S Stern; K T Nichols
Therapy with orally administered methoxsalen and ultraviolet A radiation during childhood increases the risk of basal cell carcinoma. The PUVA Follow-up Study.
The Journal of pediatrics 1996;129(6):915-7.
1996: Robert S Stern
Managed care and the treatment of skin diseases. Dermatologists do it less often.
Archives of dermatology 1996;132(9):1039-42.
1996: Robert S Stern
The pattern of topical corticosteroid prescribing in the United States, 1989-1991.
Journal of the American Academy of Dermatology 1996;35(2 Pt 1):183-6.
1996: Robert S Stern
Acne therapy. Medication use and sources of care in office-based practice.
Archives of dermatology 1996;132(7):776-80.
1996: K E Mckenna; Robert S Stern
The outcomes movement and new measures of the severity of psoriasis.
Journal of the American Academy of Dermatology 1996;34(3):534-8.
1995: K E McKenna; Robert S Stern
Photosensitivity associated with combined UV-B and calcipotriene therapy.
Archives of dermatology 1995;131(11):1305-7.
1995: Robert S Stern
Epidemiology of psoriasis.
Dermatologic clinics 1995;13(4):717-22.
1995: Robert S Stern; E Fitzgerald; Charles Ellis; N Lowe; Michael T Goldfarb; R D Baughman
The safety of etretinate as long-term therapy for psoriasis: results of the etretinate follow-up study.
Journal of the American Academy of Dermatology 1995;33(1):44-52.
1995: Robert S Stern; L A Steinberg
Epidemiology of adverse cutaneous reactions to drugs.
Dermatologic clinics 1995;13(3):681-8.
1994: Robert S Stern
Drug promotion for an unlabeled indication--the case of topical tretinoin.
The New England journal of medicine 1994;331(20):1348-9.
1994: Robert S Stern
Ocular lens findings in patients treated with PUVA. Photochemotherapy Follow-Up-Study.
The Journal of investigative dermatology 1994;103(4):534-8.
1994: Robert S Stern; N Laird
The carcinogenic risk of treatments for severe psoriasis. Photochemotherapy Follow-up Study.
Cancer 1994;73(11):2759-64.
1994: Robert S Stern; J S Dover; J A Levin; K A Arndt
Laser therapy versus cryotherapy of lentigines: a comparative trial.
Journal of the American Academy of Dermatology 1994;30(6):985-7.
1994: Robert S Stern
Epidemiology of skin disease in HIV infection: a cohort study of health maintenance organization members.
The Journal of investigative dermatology 1994;102(6):34S-37S.
1994: Joel S Weissman; Robert S Stern; Arnold M Epstein
The impact of patient socioeconomic status and other social factors on readmission: a prospective study in four Massachusetts hospitals.
Inquiry : a journal of medical care organization, provision and financing 1994;31(2):163-72.
1993: Robert S Stern; C Nelson
The diminishing role of the dermatologist in the office-based care of cutaneous diseases.
Journal of the American Academy of Dermatology 1993;29(5 Pt 1):773-7.
1993: S A Coopman; R A Johnson; Richard Platt; Robert S Stern
Cutaneous disease and drug reactions in HIV infection.
The New England journal of medicine 1993;328(23):1670-4.
1993: S D DeCoste; Robert S Stern
Diagnosis and treatment of nevomelanocytic lesions of the skin. A community-based study.
Archives of dermatology 1993;129(1):57-62.
1993: Robert S Stern; E Albengres; J Carlson; D Chen; C Kreft; W Dai; M Joseph; H Tilson; B E Wiholm; C Kraft
An international comparison of case definition of severe adverse cutaneous reactions to medicines.
Drug safety : an international journal of medical toxicology and drug experience 1993;8(1):69-77.
1992: D S Preston; Robert S Stern
Nonmelanoma cancers of the skin.
The New England journal of medicine 1992;327(23):1649-62.
1992: Robert S Stern
The prevalence of acne on the basis of physical examination.
Journal of the American Academy of Dermatology 1992;26(6):931-5.
1991: Robert S Stern; R Lange
Outcomes of pregnancies among women and partners of men with a history of exposure to methoxsalen photochemotherapy (PUVA) for the treatment of psoriasis.
Archives of dermatology 1991;127(3):347-50.
1990: Robert S Stern
Genital tumors among men with psoriasis exposed to psoralens and ultraviolet A radiation (PUVA) and ultraviolet B radiation. The Photochemotherapy Follow-up Study.
The New England journal of medicine 1990;322(16):1093-7.
1990: Arnold M Epstein; Robert S Stern; Joel S Weissman
Do the poor cost more? A multihospital study of patients' socioeconomic status and use of hospital resources.
The New England journal of medicine 1990;322(16):1122-8.
1990: C R Taylor; Robert S Stern; J J Leyden; B A Gilchrest
Photoaging/photodamage and photoprotection.
Journal of the American Academy of Dermatology 1990;22(1):1-15.
1990: H L Chan; Robert S Stern; K A Arndt; J Langlois; S S Jick; H Jick; Alexander Walker
The incidence of erythema multiforme, Stevens-Johnson syndrome, and toxic epidermal necrolysis. A population-based study with particular reference to reactions caused by drugs among outpatients.
Archives of dermatology 1990;126(1):43-7.
1989: Robert S Stern
Epidemiologic assessment of adverse drug effects.
Seminars in dermatology 1989;8(3):136-40.
1989: Robert S Stern; H L Chan
Usefulness of case report literature in determining drugs responsible for toxic epidermal necrolysis.
Journal of the American Academy of Dermatology 1989;21(2 Pt 1):317-22.
1989: J S Dover; Marian T McEvoy; C F Rosen; K A Arndt; Robert S Stern
Are topical corticosteroids useful in phototherapy for psoriasis?
Journal of the American Academy of Dermatology 1989;20(5 Pt 1):748-54.
1989: Robert S Stern
Risk assessment of PUVA and cyclosporine. Lessons from the past; challenges for the future.
Archives of dermatology 1989;125(4):545-7.
1988: Robert S Stern
The benefits, costs and risks of topical tar preparations in the treatment of psoriasis: considerations of cost effectiveness.
Annals of the Academy of Medicine, Singapore 1988;17(4):473-6.
1988: J S Dover; B R Smoller; Robert S Stern; S Rosen; K A Arndt
Low-fluence carbon dioxide laser irradiation of lentigines.
Archives of dermatology 1988;124(8):1219-24.
1988: Arnold M Epstein; Robert S Stern; J Tognetti; Colin B Begg; R M Hartley; E Cumella; John Z Ayanian
The association of patients' socioeconomic characteristics with the length of hospital stay and hospital charges within diagnosis-related groups.
The New England journal of medicine 1988;318(24):1579-85.
1988: M Bigby; Robert S Stern
Adverse reactions to isotretinoin. A report from the Adverse Drug Reaction Reporting System.
Journal of the American Academy of Dermatology 1988;18(3):543-52.
1987: Robert S Stern; B U Wintroub
Adverse drug reactions: reporting and evaluating cutaneous reactions.
Advances in dermatology 1987;2():3-17.
1986: Robert S Stern
Identifying adverse reactions to drugs. Reporting systems.
Clinics in dermatology 1986;4(1):15-22.